Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency

Hui Wen Yao, Li Chiu Wang, Hsien Yang Tsai, Yi Hsuan Fang, Chunfu Zheng, Shun Hua Chen, Sheng Min Hsu

研究成果: Article同行評審

1 引文 斯高帕斯(Scopus)


Bortezomib suppressing NF-κB activity is an effective therapy for patients with myeloma or lymphoma. However, this drug can cause adverse effects, neutropenia, and recurrent infections of herpes viruses. Among herpes viruses, HSV-1 can reactivate to induce mortality. The important issues regarding how bortezomib diminishes neutrophils, whether bortezomib can induce HSV-1 reactivation, and how bortezomib exacerbates HSV-1 infection, need investigation. Using the murine model, we found that bortezomib induced HSV-1 reactivation. Bortezomib diminished neutrophil numbers in organs of uninfected and HSV-1-infected mice and turned a nonlethal infection to lethal with elevated tissue viral loads. In vitro results showed that bortezomib and HSV-1 collaborated to enhance the death and apoptosis of mouse neutrophils. The leukocyte deficiency induced by chemotherapies is generally believed to be the cause for aggravating virus infections. Here we show the potential of pathogen to exacerbate chemotherapy-induced leukocyte deficiency.

頁(從 - 到)105-112
期刊Journal of Leukocyte Biology
出版狀態Published - 2020 1月 1

All Science Journal Classification (ASJC) codes

  • 免疫學和過敏
  • 免疫學
  • 細胞生物學


深入研究「Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency」主題。共同形成了獨特的指紋。